DVA - Insider Unloading: Javier Rodriguez Sells $33.90M Worth Of DaVita Shares | Benzinga
On December 18, a recent SEC filing unveiled that Javier Rodriguez, Chief Executive Officer at DaVita (NYSE:DVA) made an insider sell.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Monday showed that Rodriguez sold 311,581 shares of DaVita. The total transaction amounted to $33,900,012.
DaVita's shares are actively trading at $106.45, experiencing a down of 0.45% during Tuesday's morning session.
About DaVita
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
DaVita: Delving into Financials
Revenue Growth: DaVita's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2023, the company achieved a revenue growth rate of approximately 5.85%. This indicates a ...